Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical Utility of the MDASI-BT in Patients with Brain Metastases

Similar presentations


Presentation on theme: "Clinical Utility of the MDASI-BT in Patients with Brain Metastases"— Presentation transcript:

1 Clinical Utility of the MDASI-BT in Patients with Brain Metastases
Terri S. Armstrong, PhD, Ibrahima Gning, DrPH, Tito R. Mendoza, PhD, Jeffrey S. Weinberg, MD, Mark R. Gilbert, MD, Melissa L. Tortorice, BS, Charles S. Cleeland, PhD  Journal of Pain and Symptom Management  Volume 37, Issue 3, Pages (March 2009) DOI: /j.jpainsymman Copyright © 2009 U.S. Cancer Pain Relief Committee Terms and Conditions

2 Fig. 1 Cluster analysis of the MDASI-BT symptoms with dendrogram (n=124). Distances between symptom scores as rated by patients were calculated using squared Euclidian distances to form clusters of symptoms. Graphical displays with dendrograms showing cohesion between clusters were done using Ward's method. Shaded areas represent the commonly seen patterns of gastrointestinal and affective clusters as described in other symptom validation studies. Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman ) Copyright © 2009 U.S. Cancer Pain Relief Committee Terms and Conditions

3 Fig. 2 Symptom severity by good (90–100) versus poor (30–80) KPS (n=124). Note: Mean differences are not significant for nausea, vomiting, seizures, and change in bowel patterns. Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman ) Copyright © 2009 U.S. Cancer Pain Relief Committee Terms and Conditions


Download ppt "Clinical Utility of the MDASI-BT in Patients with Brain Metastases"

Similar presentations


Ads by Google